OMERS ADMINISTRATION Corp bought a new position in shares of Kewaunee Scientific Corporation (NASDAQ:KEQU - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,200 shares of the technology company's stock, valued at approximately $284,000. OMERS ADMINISTRATION Corp owned 0.25% of Kewaunee Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently added to or reduced their stakes in KEQU. American Century Companies Inc. boosted its holdings in shares of Kewaunee Scientific by 43.4% in the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock valued at $1,937,000 after buying an additional 14,889 shares during the period. Ritholtz Wealth Management raised its stake in shares of Kewaunee Scientific by 42.2% in the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after acquiring an additional 5,330 shares during the last quarter. Jane Street Group LLC bought a new stake in Kewaunee Scientific in the fourth quarter valued at approximately $300,000. IFP Advisors Inc lifted its stake in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after acquiring an additional 360 shares during the last quarter. Finally, Bank of America Corp DE increased its position in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after acquiring an additional 443 shares during the period. 32.69% of the stock is owned by hedge funds and other institutional investors.
Kewaunee Scientific Trading Up 1.3%
NASDAQ:KEQU traded up $0.71 on Monday, reaching $54.44. The company's stock had a trading volume of 4,317 shares, compared to its average volume of 17,473. Kewaunee Scientific Corporation has a 12-month low of $30.33 and a 12-month high of $71.33. The company has a quick ratio of 1.59, a current ratio of 2.20 and a debt-to-equity ratio of 0.92. The stock has a 50 day moving average price of $56.75 and a 200 day moving average price of $45.95. The firm has a market cap of $160.60 million, a price-to-earnings ratio of 14.21 and a beta of 0.75.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings results on Wednesday, June 25th. The technology company reported $1.95 earnings per share for the quarter. The company had revenue of $77.15 million for the quarter. Kewaunee Scientific had a return on equity of 26.02% and a net margin of 4.74%.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.
View Our Latest Report on Kewaunee Scientific
Insider Activity at Kewaunee Scientific
In other news, CFO Donald T. Gardner III sold 3,000 shares of the company's stock in a transaction on Thursday, July 24th. The shares were sold at an average price of $58.59, for a total value of $175,770.00. Following the sale, the chief financial officer directly owned 14,564 shares of the company's stock, valued at approximately $853,304.76. This represents a 17.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 13.30% of the company's stock.
Kewaunee Scientific Company Profile
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.